Research and
Drug Discovery

AI can achieve "time and cost savings of 25–50%"* in drug discovery up to the preclinical stage.

Lenovo AI Visionboard

Business Opportunity:

  • Accelerate the discovery and development of new and innovative treatments
  • Streamline the process, reduce costs, and improve the accuracy of clinical trials

Drug Discovery and
Development

AI accelerates the drug discovery process by analyzing biological data, predicting molecular interactions, and identifying potential drug candidates. This reduces the time and cost involved in bringing new drugs to market.

*Source: Nature.com
  • Streamline the Discovery Process: AI-powered analytics quickly identify potential drug candidates, reducing the time and cost associated with traditional methods.
  • Enhance Efficacy and Safety: AI-driven insights improve drug efficacy and safety by predicting molecular interactions and identifying potential side effects.
  • Unlock New Therapies: AI-powered drug repurposing and target identification enable the development of new treatments for previously untreatable diseases.
  • Optimize Clinical Trials: AI streamlines clinical trials by identifying the most promising candidates, reducing operational costs, and improving patient outcomes.

Institute for Basic Science - South Korea

With an ultra-efficient high-performance computing (HPC) platform, built on Lenovo servers, the Institute for Basic Science is helping researchers drive scientific progress.

Read Case Study
Lenovo
Lenovo